You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Norway

Jun 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Stable growth in value sales for 2011

Consumer health recorded a marginal gain in constant value terms in 2011. The largest categories, vitamins and dietary supplements and OTC medicines, recorded flat growth in constant value terms at lower rates than the respective CAGRs for the review period. A more competitive environment with greater focus on value pricing is reflected in the overall growth rates.

Prudent spending habits emerge

Although Norway emerged relatively unscathed from the global financial crisis, consumption has not returned to the pre-crisis level recorded in 2007. Norwegians may have suffered less than their European neighbours, but consumer confidence dipped after experiencing the discomfort that accompanies financial uncertainty. Norwegian consumers are spending money prudently in all categories of consumer products. Concern about spending prudently and getting “value for money” differs widely for consumer health products according to the actual product and distribution channel. The consumer health products included in this report cover a range of categories where demand elasticity varies.

Global players drive competition

Multinationals have a well-established presence in consumer health in Norway. Five players – Orkla Group, Takeda Pharmaceuticals, Weifa, Novartis, and Johnson & Johnson – accounted for almost half of current value sales in 2011. With the exception of Weifa, all of the leading companies in Norway are multinational, bringing global expertise in terms of product development, marketing and distribution. Domestic player Weifa has set strategic goals to move beyond Norway’s borders and become a leading supplier in consumer health in the Nordic countries.

Important role for non-store retailing

Non-store retailers are important suppliers in all channels of consumer health. Liberalisation of the chemists/pharmacies retail channel created an environment where internet retailing’s value share increased by 8% between 2010 and 2011.

In 2011, with the launch of www.apotek1.no, all of the major chemist/pharmacy chains had internet retailing operations. Chemist/pharmacy chains are trusted sources of medical advice and this is reflected in the online operations of two players in particular, Apotek1 and Vitus Apotek. Both retailers provide extensive advice about the products and pictures. Vitus Apotek even offers a chat facility through which consumers can get advice from a qualified pharmacist.

Moderate increase predicted

Consumer health is expected to register a CAGR of 2% in constant value terms over the forecast period, a slightly lower rate than over the review period. The focus on “value for money” and expansion of mass retail will exert downward pressure on prices.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Norway with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Norway for free:

The Consumer Health in Norway market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Norway?
  • What are the major brands in Norway?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Norway - Industry Overview

EXECUTIVE SUMMARY

Stable growth in value sales for 2011

Prudent spending habits emerge

Global players drive competition

Important role for non-store retailing

Moderate increase predicted

KEY TRENDS AND DEVELOPMENTS

Consumption declines in spite of rising disposable household income

Multinationals have a bigger role in Norway

Greater access to internet adds a new dimension to marketing consumer health products

New products for an ageing population

Government-led health initiatives

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

De-listing or de-reimbursement

Bioequivalent/Generics

Combination products

Advertising

Packaging

Labelling

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Norway - Company Profiles

Axellus AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Axellus AS: Competitive Position 2011

Midsona Norge AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Midsona Norge AS: Competitive Position 2011

Nycomed Pharma AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 11 Nycomed Pharma AS: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 12 Nycomed Pharma AS: Competitive Position 2011

VitaeLab AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Vitae Pro AS: Competitive Position 2011

Weifa AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 18 Weifa AS: Production 2011

COMPETITIVE POSITIONING

  • Summary 19 Weifa AS: Competitive Position 2011

Adult Mouth Care in Norway - Category Analysis

HEADLINES

TRENDS

  • More attention is focused on prevention of gum disease and treatment of mouth ailments as the population ages. Mouth ailments, such as inflammation of gums and canker sores, are a common problem in Norway. More than 90% of Norwegians experience gum inflammation at least once during their lifetime while over 50% of those aged over 40 experience gingivitis. These problems are usually treated by Rx medications or self-care remedies such as changes in eating habits or stress reduction.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline’s Corsodyl remained the clear leader with for 98% of retail value sales in 2011. Corsodyl is available in two formats, a dental gel applied locally and a mouthwash to prevent build-up of bacteria on teeth and gums as well as to prevent infections.

PROSPECTS

  • Adult mouth care is expected to register a CAGR of 1% in constant value terms over the forecast period to reach NOK18 million in 2016. Sales are expected to increase steadily throughout the forecast period as an ageing population becomes more concerned with oral hygiene. Growth is expected to be driven by products that prevent gum inflammation – a common problem that most Norwegians would prefer to avoid.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Norway - Category Analysis

HEADLINES

TRENDS

  • The Norwegian Medicines Agency continues to liberalise retailing of OTC medicines in Norway. The list of medicines permitted to be sold in mass retail outlets expanded after liberalisation. The government decided to permit self-service sales of some bestselling brands. In 2011, customers can opt for self-service purchases of paracetamol and ibuprofen including Burana, Ibumetin, Ibuprofen, Ibuprox, Ibux, Ibumetin, Panodil, Paracet, Paracetamol and Pinex. The new arrangement is likely to result in higher value sales for brands with high recognition.

SWITCHES

COMPETITIVE LANDSCAPE

  • Weifa dominated analgesics with a value share of 70% in 2011. The remaining value share was held by both multinational suppliers of brands and generic products including Actavis Nordic, Nycomed Pharma, Novartis, Orion Pharma, GlaxoSmithKline and Ratiopharm.

PROSPECTS

  • An ageing population in Norway is likely to boost sales over the forecast period. The incidence of minor aches and pains increases with an older population. This demographic trend combined with encouragement from health authorities to self-medicate is likely to contribute to higher sales.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Norway - Category Analysis

HEADLINES

TRENDS

  • Growth in constant value terms declined by 12% in 2011. Norwegians tend to prioritise alternative techniques for rest and relaxation before seeking advice from a doctor. The most sought-after remedies to resolve relaxation and sleeping problems are available on prescription.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cederroth’s Valerina brand led OTC calming and sleeping medicines with an overwhelming value share of 90%. Others accounted for the remaining value share.

PROSPECTS

  • Few changes are expected in the competitive environment over the forecast period. Approval by the Norwegian Medicines Agency is a time-consuming process. Calming and sleeping is expected to register a CAGR of 2% in constant value terms over the forecast period to reach NOK12 million by 2016.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Norway - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies increased by 4% in current value terms in 2011. The cold, Northern European climate usually underpins demand for cough, cold, and allergy remedies. The year started with a biting Arctic winter that became milder during the rest of the year. Norwegian consumers were not coughing and sneezing as much as the previous year.

SWITCHES

COMPETITIVE LANDSCAPE

  • Four companies accounted for 59% of value sales in 2011 in OTC cold, cough, and allergy remedies. Novartis was the leading player with 18%, followed by Nidar with 17%, Galleberg with 14% and Nycomed Pharma with 10%. Novartis and Nycomed Pharma were present in OTC nasal sprays and antihistamines while Nidar and Galleberg led medicated confectionery.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Norway - Category Analysis

HEADLINES

TRENDS

  • Good nutrition is in focus in Norway with extensive coverage in magazines, television, schools, and through health organisations. Health authorities have documented a clear tendency towards excess weight and aim to reverse this trend. The Norwegian Institute for Public Health issues nutritional guidelines annually which recommends 50% of food intake comes from carbohydrates. However, there is more interest in losing weight by following a low-carb diet, which recommends 50% of food intake from fat. The interest is greater in the low-carb diet than the nutritional guidelines. Discussion centres on the importance of carbs vs fat and how that affects general health, including digestion.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Laboratories, a Johnson & Johnson subsidiary, led digestive remedies with a 27% share of retail value sales in 2011. The company has leading brands in H2 blockers, laxatives, antiflatulents and motion sickness remedies. H2 blockers Pepcid and Pepcid Duo accounted for 70% of McNeil Laboratories’s retail value share of that category in 2011. Although Pepcid and Pepcid Duo are well-established brands, some consumers with more severe problems with heartburn may migrate to the newly switched proton pump inhibitors from Nycomed Pharma, which provide longer-lasting relief.

PROSPECTS

  • In contrast to many of Norway’s European neighbours, the Norwegian economy is expected to perform well providing Norwegians with higher levels of disposable income. As affluence grows, Norwegians are likely to continue to eat the luxury foods which frequently cause constipation and heartburn in spite of public health initiatives.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Norway - Category Analysis

HEADLINES

TRENDS

  • Expenditure on ear care products for minor annoyances remained discretionary in 2011 despite the ever-growing interest in good health. OTC products are usually limited to ear drops to loosen ear wax.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion Pharma led ear care with a 44% share of retail value sales through the Revaxør brand of ear drops, used to loosen ear wax. Revaxør is sold as a set with a balloon applicator and as a refill only through the major chemist/pharmacy chains.

PROSPECTS

  • There was little activity in terms of new product development for ear care over the review period and this situation is unlikely to change over the forecast period. Expenditure on ear care products for minor annoyances is considered discretionary by most Norwegians. Suppliers are unlikely to invest in developing new ear care products.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Norway - Category Analysis

HEADLINES

TRENDS

  • Value sales for emergency contraceptives increased by 1% in current value terms in 2011, a marginal gain over the previous year. Norwegian health authorities concluded the decision to make emergency contraceptives more widely available in mass distribution channels from 1 January 2009 did not impact per capita consumption. There was concern that broad distribution would move the products from an emergency solution to birth control. Norwegian health authorities were concerned that extended availability of the product would result in a strong increase in consumption. Pharmacists were concerned about potential problems associated with selling emergency contraceptives in outlets without qualified medical staff to advise about possible side effects and usage.

COMPETITIVE LANDSCAPE

  • Norlevo from Nycomed Pharma led emergency contraception in 2011 with 84% of retail value sales followed by Postinor from Schering Norge with a 16% share. Levonorgestrel, a hormone preparation, is the active ingredient in both products.

PROSPECTS

  • Health authorities are expected to continue to encourage sexually active Norwegians to prevent unwanted pregnancies by having informed and responsible sex.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2006-2011
  • Table 54 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 55 Emergency Contraception Company Shares by Value 2007-2011
  • Table 56 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 57 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Norway - Category Analysis

HEADLINES

TRENDS

  • Norwegian consumers are willing to self-medicate minor eye irritation such dry and tired eyes with standard eye drops. Consumers are purchasing eye drops more often because of increased distribution in chains and grocery outlets. Most often, the purpose of standard eye care products is to replenish tear production in order to moisten the eyes or reduce redness. The purpose of eye drops for allergy care is to reduce itching, redness and dryness caused by seasonal allergic reactions.

SWITCHES

COMPETITIVE LANDSCAPE

  • Four multinationals – Novartis, McNeil Laboratories, Actavis Nordic and Santen Norge – led eye care and accounted for 74% of retail value sales in 2011. The remaining share was held by a combination of generic and brand suppliers including Orifarm Group, Allergan Norge, Aventis Pharma, Farma Holding and Alcon Norge.

PROSPECTS

  • Eye care is expected to register a CAGR of 4% in constant value terms to reach NOK114 million in 2016. The CAGR of 4% is a decrease of two percentage points on the constant terms CAGR of the review period. Standard eye care is likely to record the fastest with a CAGR of 7% mainly due to wider distribution of a more varied selection of products.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2006-2011
  • Table 60 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 61 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 62 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 63 Eye Care Company Shares by Value 2007-2011
  • Table 64 Eye Care Brand Shares by Value 2008-2011
  • Table 65 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Norway - Category Analysis

HEADLINES

TRENDS

  • In 2011, herbal/traditional products increased by 3% in current value terms to NOK928 million. Current value growth was one percentage point lower than the CAGR of 4% for the review period.

COMPETITIVE LANDSCAPE

  • The competitive landscape for herbal/traditional products is fragmented with many players competing. Galleberg ranked first in 2011 with 15% of retail value sales through the Fisherman’s Friend brand of medicated confectionery. Fisherman’s Friend value share increased by 0.4 percentage points in 2011 through successful TV ad campaigns and the successful introduction of new flavours.

PROSPECTS

  • Consumer interest in alternative medicine and herbal/traditional products is expected to grow over the forecast period. Despite negative attitudes from health authorities, consumers are expected to retain an interest in herbal/traditional products as an alternative or complement to Rx and OTC products.

CATEGORY DATA

  • Table 67 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 68 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 69 Herbal/Traditional Products Company Shares 2007-2011
  • Table 70 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 71 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 72 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Norway - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care increased by 2% in current value terms in 2011 to NOK254 million. Growth in 2011 was one percentage point lower than the CAGR for the review period. Competition from beauty care brands and price competition among retailers dampened growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer led medicated skin care with 18% of retail value sales in 2011. The company has a strong position in antifungals where Canesten, a topical and vaginal antifungal, competes directly with Pevaryl and Daktar from McNeil. Bayer is present in other categories including nappy rash treatments through Bepanthen and Sheriproct in haemorrhoid treatments.

PROSPECTS

  • A blurring of medicated and cosmetic skin care brands is likely to characterise the forecast period. The range of skin care brands sold in the chemists/pharmacies channel has expanded to include a variety of products to treat skin problems such as rosacea and dry skin. Some brand ranges such as Decubal and Eucerin border beauty care and medicated skin care by offering some products with active ingredients and others without. Marketers will be increasingly challenged to build their medicate skin care products into brands.

CATEGORY DATA

  • Table 73 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 74 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 75 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 76 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 77 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Norway - Category Analysis

HEADLINES

TRENDS

  • In 2011, 18% of the Norwegian adult population smoked daily, with the percentage of male smokers marginally higher. The government is determined to decrease the number of smokers in Norway and takes some drastic steps to achieve its goal. On 1 January 2010, Norway was among the first countries to place a ban on the visible display of tobacco products in stores. The display ban is only one of many obstacles the government has implemented to discourage smoking. Taxes and fees, in addition to the normal 25% MVA, make the cost of smoking exorbitant. Norway led the drive to exile smokers to the outdoors in 2004.

SWITCHES

COMPETITIVE LANDSCAPE

  • Multinationals McNeil Laboratories and Novartis were the leading players in 2011, with retail value shares of 51% and 49%, respectively.

PROSPECTS

  • The Norwegian government will continue to lead initiatives to reduce smoking in Norway. These initiatives are more likely to focus on discouraging Norwegians from starting to smoke rather than motivating smokers to quit.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Norway - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition increased by 5% in current value terms in 2011 to NOK146 million. Growth in 2011 was two percentage points lower than the CAGR for the review period. Sports nutrition products have been aimed at sports enthusiasts throughout the review period. The present range and assortment requires a high level of interest and knowledge to understand the products. Slower growth indicates sports nutrition is maturing for the sports enthusiast segment and needs to reach a larger target group to boost sales.

COMPETITIVE LANDSCAPE

  • Bringwell Norway led sports nutrition with a value share of 20% in 2011 through its strong position as the distributor for the Multipower brand. Multipower is present in bars, protein powder, RTD, non-protein powder and other protein. Multipower is distributed primarily through the other non-grocery retailers channel and sport goods stores.

PROSPECTS

  • Sports nutrition is expected to see greater penetration among occasional athletes. Moving sports nutrition from the domain of hard core bodybuilding into the mainstream contributes to sales among non-typical consumers, including women.

CATEGORY DATA

  • Table 88 Sales of Sports Nutrition: Value 2006-2011
  • Table 89 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 90 Sports Nutrition Company Shares 2007-2011
  • Table 91 Sports Nutrition Brand Shares 2008-2011
  • Table 92 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Norway - Category Analysis

HEADLINES

TRENDS

  • Current value increased by 2% in 2011 for vitamins and dietary supplements, a rate one percentage point lower than the CAGR of 3% for the review period. Growth was flat for both herbal/traditional dietary supplements and non-herbal/traditional dietary supplements. Value sales declined for many of the herbals as suppliers streamlined their ranges to include the most profitable products. In contrast, sales of combination herbal/traditional products increased as more products based on positioning were launched.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Axellus, an Orkla Group subsidiary, led vitamins and dietary supplements with 21% of retail value sales in 2011. The company was formed in 2007 when Orkla Group merged three of Scandinavia’s leading players in vitamins and dietary supplements – Peter Möller, Collett Pharma and Danske Droge – into one entity organised within the Orkla Brands division. Since the merger, Axellus has focused on developing high-volume brands in both herbal/traditional and non-herbal/traditional dietary supplements for distribution primarily through grocery retailers, the traditional channel for Orkla Brands. Axellus led both fish oils and omega-3-6-9 through the Möller’s brand, which held a value share of 12% of overall vitamins and dietary supplements in 2011 and accounted for 80% of the company’s overall turnover.

PROSPECTS

  • The ageing Norwegian population is expected to buoy sales of vitamins and dietary supplements. Industry sources report middle-aged Norwegians are the primary consumers for this category, especially dietary supplements. Categories comprised of products targeted at the ailments of middle age such as soya and calcium supplements are likely to perform well.

CATEGORY DATA

  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 96 Dietary Supplements by Positioning 2006-2011
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Vitamins Brand Shares by Value 2008-2011
  • Table 100 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 20 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Norway - Category Analysis

HEADLINES

TRENDS

  • Low-carb diets were in focus in 2011. One in four women are dieting and many choose a low-carb plan according to Norwegian research bureau MMI Synovate. Although 57% of survey respondents considered low-carb plans to be a fad, almost half of dieters are reducing their intake of bread, pasta, potatoes and rice in order to lose weight. Further investigation shows the remaining 43% of dieters choose to lose weight as follows: 17% follow the advice of Statens Ernæringsråd (the Government Nutrition Council), 8% belong to a Norwegian diet club called Grete Roede, 7% use the Fedon Linderg plan and 5% eat less than usual.

COMPETITIVE LANDSCAPE

  • Axellus was the leading company in weight management with a retail value share of 31% in 2011. Herbalife ranked second with 17% followed by Med-Eq with 11%.

PROSPECTS

  • The Norwegian Institute for Public Health predicts the trend towards a higher incidence of excess weight is expected to continue over the forecast period. The Institute will continue to launch health initiatives in cooperation with other Norwegian health organisations to reverse this trend. In spite of public health initiatives, it will be difficult to alter this trend within the relatively short time framework from 2011 to 2016.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2006-2011
  • Table 104 Sales of Weight Management: % Value Growth 2006-2011
  • Table 105 Weight Management Company Shares 2007-2011
  • Table 106 Weight Management Brand Shares 2008-2011
  • Table 107 Forecast Sales of Weight Management: Value 2011-2016
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Norway - Category Analysis

HEADLINES

TRENDS

  • Wound care sales are mature in Norway. Segmentation is a key driver of retail value growth for the category. This is highlighted by new product developments such as Compeed Band Aid for Finger Cracks.

COMPETITIVE LANDSCAPE

  • Actavis Nordic led wound care by a wide margin in 2011 with 39% of retail value sales. Beiersdorf ranked second with 15% followed by 3M Norge with 12%.

PROSPECTS

  • Bestsellers are likely to offer benefits in terms of healing properties, alleviating pain and attractive coverage. Higher product complexity will necessitate better communication with consumers via the internet, packaging or pharmacy staff.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2006-2011
  • Table 110 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 111 Wound Care Company Shares by Value 2007-2011
  • Table 112 Wound Care Brand Shares by Value 2008-2011
  • Table 113 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Blueberry
            • Cranberry
            • Roseroot
            • Soya
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Paediatric Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Paediatric Consumer Health
        • Paediatric Analgesics
          • Paediatric Acetaminophen
          • Paediatric Aspirin
          • Paediatric Combination Products - Analgesics
          • Paediatric Diclofenac
          • Paediatric Dipyrone
          • Paediatric Ibuprofen
          • Paediatric Ketoprofen
          • Paediatric Naproxen
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Paediatric Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Paediatric Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing
    • Smoking population - number of adult smokers
    • Smoking prevalence - % of adult population

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!